The antiherpes drug (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVdU) interferes with formation of N-Linked and of O-Linked oligosaccharides of the herpes simplex virus type 1 glycoprotein C

Abstract
No abstract available